Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Will Moderna's Rally Continue?
06:35am, Monday, 26'th May 2025
Moderna (NASDAQ: MRNA) has caught the market off guard with a significant recovery in recent days – reaching current levels of approximately $27 after hitting a five-year low of $23.15 last week –
Moderna files application for updated COVID vaccine
04:19pm, Friday, 23'rd May 2025
Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug Administration.
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
04:05pm, Friday, 23'rd May 2025
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spike
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot
11:51am, Thursday, 22'nd May 2025
Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.
Moderna Stock Looks Ripe for a Short Squeeze
07:15am, Thursday, 22'nd May 2025
Moderna Inc. NASDAQ: MRNA is down 35% in 2025, making it one of the worst-performing stocks among medical stocks and the broader market. Not surprisingly, the stock is down over 80% in the last 12 mon
MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots
09:41am, Wednesday, 21'st May 2025
Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and BioNTech stocks.
Moderna withdraws application for COVID-flu combination vaccine
07:12am, Wednesday, 21'st May 2025
Moderna said on Wednesday it had withdrawn the pending application for its flu and COVID combination vaccine candidate for adults aged 50 years and older.
Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19
07:00am, Wednesday, 21'st May 2025
CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdra
Moderna shares surge as new FDA vaccine framework eases investor concerns
01:09pm, Tuesday, 20'th May 2025
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares jumped more than 6.5% on Tuesday after the US Food and Drug Administration unveiled a new framework for COVID-19 vaccine approvals that analysts said largely
The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.
12:22pm, Tuesday, 20'th May 2025
The FDA said Tuesday it will limit future Covid vaccines to older and at-risk Americans. The move buoyed Moderna, BioNTech and Novavax.
Top Stock Movers Now: Viking, Moderna, Uber Technologies, and More
12:10pm, Tuesday, 20'th May 2025
U.S. equities were lower at midday, dragged by tech and travel stocks. The Dow Jones Industrial Average, S&P 500, and Nasdaq were all lower.
Moderna: After A Crash From $500 To $25, I'm Buying This "Call Option" On Pandemics And Cancer
09:43am, Tuesday, 20'th May 2025
Moderna's share price has collapsed from $500 to $25, but I believe the selloff is overdone, and the stock is deeply oversold. Short squeeze potential, a robust pipeline, and long-term mRNA/AI opportu
S&P500 and Nasdaq Index: Consumer Data Sinks Sentiment, Super Micro, Moderna Rally
12:00pm, Friday, 16'th May 2025
S&P 500 and Nasdaq edge higher mid-session as weak sentiment data tempers gains. Traders assess inflation risks and tariff uncertainty.
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
05:30am, Friday, 16'th May 2025
Equity markets are full of bargains -- stocks that have performed terribly in recent months, whether due to trade-related marketwide issues or company-specific troubles, but could bounce back once thi
Cautious? Risky? Our Volatility Scorecard Can Help
11:08am, Tuesday, 13'th May 2025
Subscribers to Chart of the Week received this commentary on Sunday, May 11.
